Free Trial

Isthmus Partners LLC Acquires Shares of 46,402 Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health logo with Medical background

Isthmus Partners LLC acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 46,402 shares of the company's stock, valued at approximately $1,622,000.

A number of other hedge funds also recently modified their holdings of OPCH. Vanguard Group Inc. boosted its stake in Option Care Health by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after buying an additional 75,313 shares in the last quarter. Wellington Management Group LLP increased its holdings in Option Care Health by 84.6% in the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after purchasing an additional 8,400,208 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Option Care Health by 17.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after purchasing an additional 591,042 shares in the last quarter. Northern Trust Corp increased its holdings in shares of Option Care Health by 11.8% during the fourth quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock valued at $60,934,000 after acquiring an additional 278,158 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of Option Care Health during the fourth quarter valued at approximately $60,219,000. Institutional investors own 98.05% of the company's stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, JMP Securities reiterated a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a research report on Wednesday, June 18th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $35.50.

View Our Latest Report on Option Care Health

Option Care Health Trading Down 1.1%

NASDAQ OPCH traded down $0.35 on Wednesday, hitting $30.39. The company's stock had a trading volume of 1,332,587 shares, compared to its average volume of 1,830,977. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The company has a current ratio of 1.54, a quick ratio of 1.02 and a debt-to-equity ratio of 0.82. The company's 50-day simple moving average is $31.66 and its 200 day simple moving average is $31.52. The firm has a market cap of $4.98 billion, a P/E ratio of 24.51, a PEG ratio of 1.86 and a beta of 0.73.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The firm's quarterly revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.26 earnings per share. Research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

About Option Care Health

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Read More

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines